• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非那西丁固体分散体的溶解热力学与红外光谱

Thermodynamics of dissolution and infrared-spectroscopy of solid dispersions of phenacetin.

作者信息

Gerasimov Alexander V, Varfolomeev Mikhail A, Ziganshin Marat A, Gorbatchuk Valery V, Rakipov Il'naz T, Klimovitskii Alexander E, Usmanova Liana S

机构信息

Department of Physical Chemistry, Butlerov Institute of Chemistry, Kazan Federal University, Kremlevskaya 18, Kazan 420008, Russia.

出版信息

J Adv Pharm Technol Res. 2016 Jan-Mar;7(1):6-12. doi: 10.4103/2231-4040.169874.

DOI:10.4103/2231-4040.169874
PMID:26955604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4759984/
Abstract

In this work enthalpies of dissolution in water of polyethylene glycols (PEGs) having an average molecular weight of 1000 and 1400, Pluronic-F127, phenacetin as well as the composites prepared from them were measured using solution calorimetry at 298.15 K. Intermolecular interaction energies of polymer-phenacetin were calculated on the basis of an additive scheme. It was shown that for mixtures with high content of polymer (>90 wt%) Pluronic-F127 has the highest solubilizing effect, while for mixtures with (4-6):1 polymer: phenacetin ratio the best solubilizing agent is PEG-1400. Infrared-spectra showed a decrease of the number of self-associated molecules of phenacetin with increasing of polymer content in the composites. The obtained results enabled us to identify the features of intermolecular interactions of polymers with a model hydrophobic drug and may be used for optimizing the conditions for preparing solid dispersions based on hydrophilic polymers.

摘要

在这项工作中,使用溶液量热法在298.15 K下测量了平均分子量为1000和1400的聚乙二醇(PEG)、普朗尼克-F127、非那西丁以及由它们制备的复合材料在水中的溶解焓。基于加和方案计算了聚合物-非那西丁的分子间相互作用能。结果表明,对于聚合物含量高(>90 wt%)的混合物,普朗尼克-F127具有最高的增溶效果,而对于聚合物与非那西丁比例为(4-6):1的混合物,最佳增溶剂是PEG-1400。红外光谱显示,随着复合材料中聚合物含量的增加,非那西丁自缔合分子的数量减少。所得结果使我们能够确定聚合物与模型疏水药物分子间相互作用的特征,并可用于优化基于亲水性聚合物制备固体分散体的条件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/5601fd222630/JAPTR-7-6-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/acd172f884cc/JAPTR-7-6-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/65dc7c284464/JAPTR-7-6-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/b5da5432163e/JAPTR-7-6-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/5109deb5c199/JAPTR-7-6-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/8a79f3a36a3c/JAPTR-7-6-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/3642e4007598/JAPTR-7-6-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/5601fd222630/JAPTR-7-6-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/acd172f884cc/JAPTR-7-6-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/65dc7c284464/JAPTR-7-6-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/b5da5432163e/JAPTR-7-6-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/5109deb5c199/JAPTR-7-6-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/8a79f3a36a3c/JAPTR-7-6-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/3642e4007598/JAPTR-7-6-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3702/4759984/5601fd222630/JAPTR-7-6-g011.jpg

相似文献

1
Thermodynamics of dissolution and infrared-spectroscopy of solid dispersions of phenacetin.非那西丁固体分散体的溶解热力学与红外光谱
J Adv Pharm Technol Res. 2016 Jan-Mar;7(1):6-12. doi: 10.4103/2231-4040.169874.
2
Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.非那西丁和保泰松与聚乙二醇8000的固体分散体的物理化学表征、药物聚合物溶解及体外评价
J Pharm Sci. 2011 Oct;100(10):4281-94. doi: 10.1002/jps.22613. Epub 2011 May 10.
3
Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.基于普朗尼克的纳米晶药物-聚合物固体分散体的机制研究
Pharm Res. 2007 Aug;24(8):1551-60. doi: 10.1007/s11095-007-9275-7. Epub 2007 Mar 23.
4
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.洛伐他汀与聚乙二醇4000和聚乙烯吡咯烷酮K30固体分散体的物理化学表征及溶出度研究
Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510.
5
Physicochemical characterization and dissolution studies of acyclovir solid dispersions with Pluronic F127 prepared by the kneading method.采用捏合法制备的阿昔洛韦与泊洛沙姆F127固体分散体的物理化学表征及溶出度研究
Acta Pharm. 2016 Mar;66(1):119-28. doi: 10.1515/acph-2016-0008.
6
Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.地西泮和替马西泮在聚乙二醇6000固体分散体中溶出度增加的机制。
Int J Pharm. 2002 Dec 5;249(1-2):45-58. doi: 10.1016/s0378-5173(02)00532-x.
7
Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.格列齐特-聚乙二醇4000固体分散体的制备与表征
Acta Pharm. 2009 Mar;59(1):57-65. doi: 10.2478/v10007-009-0001-3.
8
Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.罗非昔布-聚乙二醇4000固体分散体及基于固体分散体的片剂的特性
Pharm Dev Technol. 2005;10(4):467-77. doi: 10.1080/10837450500299701.
9
Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.辛伐他汀与普朗尼克F127固体分散体的物理化学及溶出度研究
Pharmazie. 2014 Aug;69(8):589-94.
10
Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.用于开发难溶性抗癌药物氟他胺无定形固体分散体的药物-聚合物混溶性、相互作用和沉淀抑制研究。
Drug Dev Ind Pharm. 2019 Aug;45(8):1277-1291. doi: 10.1080/03639045.2019.1606822. Epub 2019 May 21.

引用本文的文献

1
Thermodynamic Properties of 3- and 4-Ethoxyacetanilides between 80 and 480 K.80至480K温度范围内3-乙氧基乙酰苯胺和4-乙氧基乙酰苯胺的热力学性质
Molecules. 2023 Oct 11;28(20):7027. doi: 10.3390/molecules28207027.
2
Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration.用于吸入给药的聚乙烯吡咯烷酮 K29-32 固体分散体的微球颗粒。
Biomed Res Int. 2018 Jan 10;2018:2412156. doi: 10.1155/2018/2412156. eCollection 2018.
3
A study of the formation of magnetically active solid dispersions of phenacetin using atomic and magnetic force microscopy.

本文引用的文献

1
Interactions between drugs and polymers influencing hot melt extrusion.药物与聚合物之间的相互作用影响热熔挤出。
J Pharm Pharmacol. 2014 Feb;66(2):148-66. doi: 10.1111/jphp.12183. Epub 2013 Dec 11.
2
Molecular dynamics simulations on aqueous two-phase systems - Single PEG-molecules in solution.水两相系统的分子动力学模拟——溶液中的单个聚乙二醇分子
BMC Biophys. 2012 Aug 8;5:14. doi: 10.1186/2046-1682-5-14.
3
Characterization and stability of solid dispersions based on PEG/polymer blends.基于 PEG/聚合物共混物的固体分散体的特性和稳定性。
一项使用原子力显微镜和磁力显微镜对非那西丁磁性活性固体分散体形成的研究。
J Adv Pharm Technol Res. 2017 Jan-Mar;8(1):2-7. doi: 10.4103/2231-4040.197331.
Int J Pharm. 2010 May 10;390(2):165-73. doi: 10.1016/j.ijpharm.2010.01.039. Epub 2010 Feb 10.
4
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.固体分散体作为提高难溶性药物口服生物利用度的策略。
Drug Discov Today. 2007 Dec;12(23-24):1068-75. doi: 10.1016/j.drudis.2007.09.005. Epub 2007 Oct 30.
5
Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion.第一部分:热熔挤出法制备的尼莫地平固体分散体的表征
Drug Dev Ind Pharm. 2007 Jul;33(7):791-802. doi: 10.1080/03639040601050213.
6
Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.基于普朗尼克的纳米晶药物-聚合物固体分散体的机制研究
Pharm Res. 2007 Aug;24(8):1551-60. doi: 10.1007/s11095-007-9275-7. Epub 2007 Mar 23.
7
Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.使用含有普朗尼克F-68的固体分散体提高ABT-963的生物利用度。
Int J Pharm. 2004 Nov 22;286(1-2):69-80. doi: 10.1016/j.ijpharm.2004.08.009.
8
Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations.利托那韦-聚乙二醇8000无定形固体分散体:体外和体内评价
J Pharm Sci. 2004 Mar;93(3):563-70. doi: 10.1002/jps.10566.
9
Solid-state characterization of nifedipine solid dispersions.硝苯地平固体分散体的固态表征
Int J Pharm. 2002 Apr 2;236(1-2):111-23. doi: 10.1016/s0378-5173(02)00019-4.
10
Characterization and evaluation of tenoxicam coprecipitates.替诺昔康共沉淀物的表征与评价
Drug Dev Ind Pharm. 2000 Sep;26(9):925-30. doi: 10.1081/ddc-100101319.